Stimcell Energetics (STME) Cash from Operations Growth (5y) (2016 - 2026)
Stimcell Energetics (STME) Cash from Operations Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.66% |
| Nov 30, 2025 | 12.45% |
| Aug 31, 2025 | 8.61% |
| May 31, 2025 | 24.00% |
| Feb 28, 2025 | 27.35% |
| Nov 30, 2024 | 43.05% |
| Aug 31, 2024 | 35.40% |
| May 31, 2024 | 20.57% |
| Feb 29, 2024 | 23.21% |
| Nov 30, 2023 | -15.96% |
| Aug 31, 2023 | 2.83% |
| May 31, 2023 | 3.59% |
| Feb 28, 2023 | -3.88% |
| Nov 30, 2022 | 21.38% |
| Aug 31, 2022 | 6.93% |
| May 31, 2022 | 13.38% |
| Feb 28, 2022 | 10.96% |
| Nov 30, 2021 | 16.03% |
| Aug 31, 2021 | -4.18% |
| May 31, 2021 | -12.03% |